Table 3.
Comparison of Outcomes of All Patients in Our Study
Outcomes | Total (N=458) | SOD | GR | ||||
---|---|---|---|---|---|---|---|
SOD ≤ 112.5 U/mL | SOD > 112.5 U/mL | P-value | GR ≤ 52.5 U/L | GR > 52.5 U/L | P-value | ||
3-month mortality | 9 (3.0%) | 5 (8.6%) | 4 (1.6%) | 0.018 | 7 (7.3%) | 2 (1.0%) | 0.008 |
6-month mortality | 16 (5.3%) | 9 (15.5%) | 7 (2.9%) | <0.001 | 12 (12.5%) | 4 (2.0%) | <0.001 |
1-year mortality | 50 (16.6%) | 23 (39.7%) | 27 (11.1%) | <0.001 | 28 (29.2%) | 22 (10.7%) | <0.001 |
3-month independent walking rate | 58 (19.3%) | 6 (10.3%) | 52 (21.4%) | 0.055 | 10 (10.4%) | 48 (23.4%) | 0.008 |
6-month independent walking rate | 164 (54.5%) | 17 (29.3%) | 147 (60.5%) | <0.001 | 36 (37.5%) | 128 (62.4%) | <0.001 |
1-year independent walking rate | 202 (67.1%) | 22 (37.9%) | 243 (74.1%) | <0.001 | 49 (51.0%) | 153 (74.6%) | <0.001 |